Unexpected Aggravation of COVID-19 After Recovery in Three Adolescents With Chronic Neurologic Conditions: A Case Series
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The clinical severity of coronavirus disease 2019 (COVID-19) in children is usually mild. Most of the affected patients completely recovered from COVID-19 before being released from approximately 7-day quarantine. However, children with comorbidities are at risk of more severe disease and adverse outcomes. We report three cases of COVID-19-affected adolescents with underlying chronic respiratory difficulty due to neurologic diseases who showed sudden clinical aggravations at the time of discharge, even after full clinical improvement. Patient 1 is a 17-year-old boy with Ullrich congenital muscular dystrophy who had cardiopulmonary arrest 9 days after the initial COVID-19 symptoms. Patient 2 is a 17-year-old girl with intracerebral hemorrhage with infarction in bed-ridden status who had cardiopulmonary arrest 11 days after the initial symptoms. Patient 3 is a 12-year-old boy with intraventricular hemorrhage with hydrocephalus in bed-ridden status who showed multiorgan failure 10 days after the initial symptoms. Remdesivir, dexamethasone, and empirical antibiotics were administered with mechanical ventilation and intensive unit care. Among the three patients, two (patients 1 and 3) were alive, and one (patient 2) expired. Clinicians caring for adolescents with chronic neurologic and/or pulmonary disease should keep in mind that these patients could have sudden deterioration after recovery from the acute phase of COVID-19 around or after the time of discharge.
Abstract
The clinical severity of coronavirus disease 2019 (COVID-19) in children is usually mild. Most of the affected patients completely recovered from COVID-19 before being released from approximately 7-day quarantine. However, children with comorbidities are at risk of more severe disease and adverse outcomes. We report three cases of COVID-19-affected adolescents with underlying chronic respiratory difficulty due to neurologic diseases who showed sudden clinical aggravations at the time of discharge, even after full clinical improvement. Patient 1 is a 17-year-old boy with Ullrich congenital muscular dystrophy who had cardiopulmonary arrest 9 days after the initial COVID-19 symptoms. Patient 2 is a 17-year-old girl with intracerebral hemorrhage with infarction in bed-ridden status who had cardiopulmonary arrest 11 days after the initial symptoms. Patient 3 is a 12-year-old boy with intraventricular hemorrhage with hydrocephalus in bed-ridden status who showed multiorgan failure 10 days after the initial symptoms. Remdesivir, dexamethasone, and empirical antibiotics were administered with mechanical ventilation and intensive unit care. Among the three patients, two (patients 1 and 3) were alive, and one (patient 2) expired. Clinicians caring for adolescents with chronic neurologic and/or pulmonary disease should keep in mind that these patients could have sudden deterioration after recovery from the acute phase of COVID-19 around or after the time of discharge.
참고문헌 (16)
- Castellar-López J, "Recent insights into COVID-19 in children and clinical recommendations", Curr Pediatr Rev, 18, pp.121~137 (2022)
- Seon Jeong-Yeon, "Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea", Journal of Korean Medical Science, 36(20), pp.1~13 (2021), 대한의학회[DOI]
- Soo-Han Choi, "Epidemiology and clinical features of coronavirus disease 2019 in children", Clinical and Experimental Pediatrics, 63(4), pp.125~132 (2020), 대한소아청소년과학회
- Wang L, "Comparison of outcomes from COVID infection in pediatric and adult patients before and after the emergence of Omicron", medRxiv, ~ (2022)
- Di Fusco M, "COVID-19-associated hospitalizations among children less than 12 years of age in the United States", J Med Econ, 25, pp.334~346 (2022)
- Hyunju Lee, "Analysis of Critical COVID-19 Cases Among Children in Korea", Journal of Korean Medical Science, 37(1), pp.1~10 (2022), 대한의학회[DOI]
- Molteni E, "Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2", Lancet Child Adolesc Health, 5, pp.708~718 (2021)
- Nallasamy K, "Clinical profile, hospital course and outcome of children with COVID-19", Indian J Pediatr, 88, pp.979~984 (2021)
- Kwak Ji Hee, "Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019", Clinical and Experimental Pediatrics, 64(2), pp.68~75 (2021), 대한소아청소년과학회[DOI]
- Feldstein LR, "Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children(MIS-C)compared with severe acute COVID-19", JAMA, 325, pp.1074~1087 (2021)
- Lee Joon Kee, "소아 다기관 염증 증후군", Pediatric Infection and Vaccine, 28(2), pp.66~81 (2021), 대한소아감염학회[DOI]
- Gupta A, "Extrapulmonary manifestations of COVID-19", Nat Med, 26, pp.1017~1032 (2020)
- Ragab D, "The COVID-19 cytokine storm; what we know so far", Front Immunol, 11, pp.1446~ (2020)
- Manjili RH, "COVID-19 as an acute inflammatory disease", J Immunol, 205, pp.12~19 (2020)
- Shah Sweni, "COVID-19 in children: reasons for uneventful clinical course", Clinical and Experimental Pediatrics, 63(7), pp.237~238 (2020), 대한소아청소년과학회[DOI]
- Jae Hong Choi, "Risk Factors for Severe COVID-19 in Children: A Systematic Review and Meta-Analysis", Journal of Korean Medical Science, 37(5), pp.1~14 (2022), 대한의학회[DOI]